- Home
- TRIB vs TENX Comparison
TRIB vs TENX Comparison
Compare TRIB & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRIB
- TENX
- Stock Information
- Founded
- TRIB 1992
- TENX 1967
- Country
- TRIB Ireland
- TENX United States
- Employees
- TRIB N/A
- TENX N/A
- Industry
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- TRIB Health Care
- TENX Health Care
- Exchange
- TRIB Nasdaq
- TENX Nasdaq
- Market Cap
- TRIB 25.5M
- TENX 21.7M
- IPO Year
- TRIB N/A
- TENX N/A
- Fundamental
- Price
- TRIB $0.53
- TENX $5.32
- Analyst Decision
- TRIB
- TENX Strong Buy
- Analyst Count
- TRIB 0
- TENX 3
- Target Price
- TRIB N/A
- TENX $16.00
- AVG Volume (30 Days)
- TRIB 40.2K
- TENX 23.1K
- Earning Date
- TRIB 05-22-2025
- TENX 05-13-2025
- Dividend Yield
- TRIB N/A
- TENX N/A
- EPS Growth
- TRIB N/A
- TENX N/A
- EPS
- TRIB N/A
- TENX N/A
- Revenue
- TRIB $59,126,000.00
- TENX N/A
- Revenue This Year
- TRIB $11.63
- TENX N/A
- Revenue Next Year
- TRIB $10.13
- TENX N/A
- P/E Ratio
- TRIB N/A
- TENX N/A
- Revenue Growth
- TRIB N/A
- TENX N/A
- 52 Week Low
- TRIB $0.48
- TENX $2.77
- 52 Week High
- TRIB $3.55
- TENX $7.89
- Technical
- Relative Strength Index (RSI)
- TRIB 37.41
- TENX 35.01
- Support Level
- TRIB $0.51
- TENX $5.36
- Resistance Level
- TRIB $0.60
- TENX $5.75
- Average True Range (ATR)
- TRIB 0.05
- TENX 0.39
- MACD
- TRIB 0.00
- TENX -0.06
- Stochastic Oscillator
- TRIB 35.35
- TENX 10.56
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.